Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC I-138 | 2098211-50-6 | C26H23F3N6O | 1 ML
SDP

Supplier:  Medchemexpress LLC HY15336510MM/1ML

Encompass_Preferred

I-138 is an orally active, reversible inhibitor of USP1-UAF1, with an IC50 of 4.1 nM and Ki of 5.4 nM. It induces monoubiquitination of FANCD2 and PCNA in cells and eliminates USP1 autocleavage in cells. It is intended for research use only.

  • Eliminates USP1 self-lysis in HAP-1 USP1 WT and knockout cells
  • Induces monoubiquitination of FANCD2 and PCNA in MDA-MB-436 cells
  • Dose-dependently inhibits MDA-MB-436 cell viability
  • Results in USP1 inhibition and modest antitumor activity in mice bearing MDA-MB-436 tumors
  • Benefits BRCA1/2 mutant tumor inhibition in vivo when combined with Niraparib

Catalog No. 50-003-73342


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.